ANDA 73107, held by Able. Acetaminophen.
As of Nov 13, 2026, ANDA 73107 (Acetaminophen), held by Able, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Acetaminophen325MG ยท suppository;rectal | Acetaminophen | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters